Potential therapeutic mechanism of duodenal mucosal resurfacing

Affiliations

Comment

Hang Yang et al. Gastrointest Endosc. 2021 Nov.

. 2021 Nov;94(5):1015-1016.

doi: 10.1016/j.gie.2021.06.002.

¹ Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

No abstract available

Comment on

Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study.
van Baar ACG, Meiring S, Smeele P, Vriend T, Holleman F, Barlag M, Mostafavi N, Tijssen JGP, Soeters MR, Nieuwdorp M, Bergman JJGHM. van Baar ACG, et al. Gastrointest Endosc. 2021 Jul;94(1):111-120.e3. doi: 10.1016/j.gie.2020.12.021. Epub 2020 Dec 24. Gastrointest Endosc. 2021. PMID: 33359437 Clinical Trial.